Lifetime Eyecare Associates Introduces Lipiflow to Address Dry Eye Caused by Meibomian Gland Dysfunction
Lifetime Eyecare Associates, a full service eye care center, today announced it is now providing a revolutionary new treatment, LipiFlow®, for patients who suffer from dry eye caused by Meibomian Gland Dysfunction (MGD). MGD, a progressive disease that affects some 300 million people worldwide, stems from blockages in the oil-producing meibomian glands located in the eyelids. LipiFlow unblocks the glands, allowing the glands to resume the secretion of oily lipids needed for a healthy tear film.